Cargando…

Wound Healing Improvement with PHD-2 Silenced Fibroblasts in Diabetic Mice

BACKGROUND: Hypoxia-inducible factor 1α is the central regulator of the hypoxia-induced response which results in the up-regulation of angiogenic factors. Its activity is under precise regulation of prolyl-hydroxylase domain 2. We hypothesized that PHD2 silenced fibroblasts would increase the expres...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiongliang, Yan, Xiaoyu, Cheng, Liang, Dai, Jiezhi, Wang, Chunyang, Han, Pei, Chai, Yimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3869847/
https://www.ncbi.nlm.nih.gov/pubmed/24376825
http://dx.doi.org/10.1371/journal.pone.0084548
_version_ 1782296626616860672
author Zhang, Xiongliang
Yan, Xiaoyu
Cheng, Liang
Dai, Jiezhi
Wang, Chunyang
Han, Pei
Chai, Yimin
author_facet Zhang, Xiongliang
Yan, Xiaoyu
Cheng, Liang
Dai, Jiezhi
Wang, Chunyang
Han, Pei
Chai, Yimin
author_sort Zhang, Xiongliang
collection PubMed
description BACKGROUND: Hypoxia-inducible factor 1α is the central regulator of the hypoxia-induced response which results in the up-regulation of angiogenic factors. Its activity is under precise regulation of prolyl-hydroxylase domain 2. We hypothesized that PHD2 silenced fibroblasts would increase the expression of angiogenic factors, which might contribute to the improvement of the diabetic wound healing. MATERIALS AND METHODS: 50 dB/db mice were employed and randomly assigned into five groups with 10 mice in each: group 1 (untreated cell), group 2 (PHD2 silenced cell), group 3 (L-mimosine treated cells), group 4 (nontargeting siRNA treated cells) and group 5 (sham control). Fibroblasts were cultivated from the dermis of mice in each group and treated with PHD2 targeting siRNA, L-mimosine and non-targeting siRNA respectively. A fraction of the fibroblasts were employed to verify the silencing rate of PHD2 after 48 hours. The autologous fibroblasts (treated and untreated) labeled with adenovirus-GFP were implanted around the wound (Φ6mm), which was created on the dorsum of each mouse. The status of wounds was recorded periodically. Ten days postoperatively, 3 mice from each group were sacrificed and wound tissues were harvested. Molecular biological examinations were performed to evaluate the expressions of cytokines. 28 days postoperatively, the remaining mice were sacrificed. Histological examinations were performed to evaluate the densities of GFP+ cells and capillaries. RESULTS: The expression of PHD2 reduced to 12.5%, and the expressions of HIF-1α and VEGFa increased significantly after PHD2 siRNA treatment. With the increasing expressions of HIF-1α and VEGFa, the time to wound closure in group 2 was less than 2 weeks. Increased numbers of GFP+ cells and capillaries were observed in group 2. CONCLUSION: PHD2 siRNA treatment not only increased the expression of HIF1α and VEGFa, but also improved the fibroblast proliferation. These effects might contribute to the improvement of the diabetic wound healing.
format Online
Article
Text
id pubmed-3869847
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-38698472013-12-27 Wound Healing Improvement with PHD-2 Silenced Fibroblasts in Diabetic Mice Zhang, Xiongliang Yan, Xiaoyu Cheng, Liang Dai, Jiezhi Wang, Chunyang Han, Pei Chai, Yimin PLoS One Research Article BACKGROUND: Hypoxia-inducible factor 1α is the central regulator of the hypoxia-induced response which results in the up-regulation of angiogenic factors. Its activity is under precise regulation of prolyl-hydroxylase domain 2. We hypothesized that PHD2 silenced fibroblasts would increase the expression of angiogenic factors, which might contribute to the improvement of the diabetic wound healing. MATERIALS AND METHODS: 50 dB/db mice were employed and randomly assigned into five groups with 10 mice in each: group 1 (untreated cell), group 2 (PHD2 silenced cell), group 3 (L-mimosine treated cells), group 4 (nontargeting siRNA treated cells) and group 5 (sham control). Fibroblasts were cultivated from the dermis of mice in each group and treated with PHD2 targeting siRNA, L-mimosine and non-targeting siRNA respectively. A fraction of the fibroblasts were employed to verify the silencing rate of PHD2 after 48 hours. The autologous fibroblasts (treated and untreated) labeled with adenovirus-GFP were implanted around the wound (Φ6mm), which was created on the dorsum of each mouse. The status of wounds was recorded periodically. Ten days postoperatively, 3 mice from each group were sacrificed and wound tissues were harvested. Molecular biological examinations were performed to evaluate the expressions of cytokines. 28 days postoperatively, the remaining mice were sacrificed. Histological examinations were performed to evaluate the densities of GFP+ cells and capillaries. RESULTS: The expression of PHD2 reduced to 12.5%, and the expressions of HIF-1α and VEGFa increased significantly after PHD2 siRNA treatment. With the increasing expressions of HIF-1α and VEGFa, the time to wound closure in group 2 was less than 2 weeks. Increased numbers of GFP+ cells and capillaries were observed in group 2. CONCLUSION: PHD2 siRNA treatment not only increased the expression of HIF1α and VEGFa, but also improved the fibroblast proliferation. These effects might contribute to the improvement of the diabetic wound healing. Public Library of Science 2013-12-20 /pmc/articles/PMC3869847/ /pubmed/24376825 http://dx.doi.org/10.1371/journal.pone.0084548 Text en © 2013 Zhang et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Zhang, Xiongliang
Yan, Xiaoyu
Cheng, Liang
Dai, Jiezhi
Wang, Chunyang
Han, Pei
Chai, Yimin
Wound Healing Improvement with PHD-2 Silenced Fibroblasts in Diabetic Mice
title Wound Healing Improvement with PHD-2 Silenced Fibroblasts in Diabetic Mice
title_full Wound Healing Improvement with PHD-2 Silenced Fibroblasts in Diabetic Mice
title_fullStr Wound Healing Improvement with PHD-2 Silenced Fibroblasts in Diabetic Mice
title_full_unstemmed Wound Healing Improvement with PHD-2 Silenced Fibroblasts in Diabetic Mice
title_short Wound Healing Improvement with PHD-2 Silenced Fibroblasts in Diabetic Mice
title_sort wound healing improvement with phd-2 silenced fibroblasts in diabetic mice
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3869847/
https://www.ncbi.nlm.nih.gov/pubmed/24376825
http://dx.doi.org/10.1371/journal.pone.0084548
work_keys_str_mv AT zhangxiongliang woundhealingimprovementwithphd2silencedfibroblastsindiabeticmice
AT yanxiaoyu woundhealingimprovementwithphd2silencedfibroblastsindiabeticmice
AT chengliang woundhealingimprovementwithphd2silencedfibroblastsindiabeticmice
AT daijiezhi woundhealingimprovementwithphd2silencedfibroblastsindiabeticmice
AT wangchunyang woundhealingimprovementwithphd2silencedfibroblastsindiabeticmice
AT hanpei woundhealingimprovementwithphd2silencedfibroblastsindiabeticmice
AT chaiyimin woundhealingimprovementwithphd2silencedfibroblastsindiabeticmice